TXNIP and acute myeloid leukemia: All together, these findings suggest that TXNIP reduced availability, as a result of WWP1 deregulation, would promote proliferation and survival of AML blasts by buffering cellular ROS levels and fostering glucose uptake and consumption (Fig. 7).